New Publication:
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy

Home > Science Hub > New Publication:
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy
Back to the list

April 11, 2024

You might also be interested by

CellTalk Blog

Measuring Tumor Burden: Current and Emerging Approaches

January 24, 2025

More info

News

CellCarta Streamlines Kit Inventory Management for Clinical Sites with SLOPE-Powered Online Portal

January 14, 2025

More info

Webcasts & Webinars

Let's Talk: A Conversation with Dr. Thomas Powles

December 19, 2024

More info

News

Let's Talk: A Conversation with Dr. Thomas Powles

November 28, 2024

More info